Top Markets
Coin of the day
GlobeStar Therapeutics Corporation GlobeStar Therapeutics Corporation

GlobeStar Therapeutics Corporation

GSTC
Rank in Stocks #40541
GlobeStar Therapeutics Corporation is a clinical-stage biopharmaceutical firm... GlobeStar Therapeutics Corporation is a clinical-stage biopharmaceutical firm dedicated to advancing proprietary drug formulations. These innovative treatments specifically target multiple sclerosis (MS) and various other neurodegenerative disorders. Established in 2016, the company was formerly known as AngioSoma, Inc., rebranding to GlobeStar Therapeutics Corporation in July 2021. Its operations are headquartered in Richland, Washington.
Share Price
$0.0001
Last synced: 2026-08-12
Market Cap
$124.11K
Change (1 day)
0.00%
Change (1 year)
9,900.00%
Country
US
Trade GlobeStar Therapeutics Corporation (GSTC)

Category

EPS for GlobeStar Therapeutics Corporation (GSTC)
EPS as of 2026 TTM: 0
According to GlobeStar Therapeutics Corporation latest financial reports and stock price the company's current EPS (TTM) is 0. At the end of 2026 the company had a EPS of 0 equal to its 2026 EPS that were of 0.
EPS history for GlobeStar Therapeutics Corporation from 2026 to 2026
EPS at the end of each year
Year EPS Change
Not enough data for the provided dates.
EPS for similar companies or competitors
Company EPS EPS Difference Country
$17.32 -
US
$27.74 -
NL
- -
CH
- -
KR
$13.70 -
BE